BACKGROUND: Clinical stigmata of polycystic ovary syndrome include hirsutism, obesity, menstrual disturbances, and infertility. These symptoms impair health-related quality of life. Depression is also common. The relationship among depression, symptom self-perception, and quality of life in polycystic ovary syndrome is poorly understood. OBJECTIVE: We sought to investigate the relationship between healthrelated quality of life and depression in women with polycystic ovary syndrome. STUDY DESIGN: We conducted a secondary analysis of a multicenter, randomized clinical trial (Pregnancy in Polycystic Ovary Syndrome II, NCT00719186) comparing clomiphene citrate vs letrozole in the treatment of infertility. Subjects included 732 women ages 18e40 years with polycystic ovary syndrome by modified Rotterdam criteria. The validated Polycystic Ovary Syndrome Health-Related Quality of Life survey was self-administered, assessing the following domains: emotions, body hair, body weight, menstrual problems, and infertility; scores range from 1e7, with lower numbers indicating poorer quality of life. Depression was evaluated via the Primary Care Evaluation of Mental Disorders Patient Health Questionnaire. Quality-of-life scores were compared between depressed and nondepressed women. Multivariate linear regression models analyzed the association between depression and quality-of-life scores, controlling for age, body mass index, hirsutism score, and duration of infertility. RESULTS: In all, 64 women (8.4%) met criteria for depression. Depressed women reported reduced quality of life in all domains compared to nondepressed women: mood (3.1 vs 4.6, P < .001), body hair (3.5 vs 4.2, P ¼ .002), weight (2.0 vs 3.5, P < .001), menstrual problems (3.3 vs 4.1, P < .001), and infertility (1.9 vs 3.0, P < .001). Global quality-of-life score was reduced in depressed women (2.8 vs 3.9, P < .001). Impairments in quality of life in depressed women persisted in all domains after controlling for objective parameters including age, body mass index, hirsutism score, and infertility duration. CONCLUSION: Depression is associated with reduced quality of life related to polycystic ovary syndrome symptoms. Disturbances in healthrelated quality of life in depressed women are not explained by objective measures including body mass index, hirsutism scores, and duration of infertility. Depression may color the experience of polycystic ovary syndrome symptoms and should be considered when there is significant discordance between subjective and objective measures in women with polycystic ovary syndrome.
Introduction
Up to 15% of reproductive-age women are affected by polycystic ovary syndrome (PCOS). 1, 2 The diagnostic triad for PCOS comprises ovulatory dysfunction, hyperandrogenism, and polycystic ovarian morphology on ultrasound. 3 Hyperandrogenism may manifest biochemically (ie, in the serum) or clinically in the form of hirsutism and acne. Metabolic dysfunction is common in PCOS, 4, 5 related to insulin resistance, 6 and embodied in increased rates of obesity. An estimated 1 in 2 women with PCOS is obese. 7 Additionally, women with PCOS face an estimated 3e8 times increased risk of depression. 8e10 The pathophysiology explaining the elevated prevalence of depression in PCOS is unknown.
Health-related quality of life (HRQOL) is "the extent to which one's usual or expected physical, emotional and social well-being are affected by a medical condition" 11 and is an increasingly emphasized patientreported outcome. 12 Women with PCOS have been shown to have decreased HRQOL. 13, 14 Symptoms inherent in the disorder, including emotional disturbances, growth of body hair, increased body weight, menstrual problems, and infertility are frequently cited as reasons for the perturbed HRQOL. 13,15e17 Depression is also common in PCOS. 8 It has been suggested that PCOS somatic symptoms such as obesity and hirsutism are linked to depression risk; 18, 19 however, the causal direction of this association is poorly understood. Indeed, while PCOS symptoms may reduce HRQOL and contribute to depression risk, it is possible that depression itself might modulate how women perceive their symptoms and thereby HRQOL.
Understanding the connections between depression and HRQOL is a critical step toward identifying opportunities to enhance overall well-being in the PCOS population. The objective of our study was to test the hypotheses that: (1) depressed women perceive their PCOS symptoms more negatively or severely compared to nondepressed women, and (2) that differences in symptom self-perception are not explained by differences in objective clinical measures.
Materials and Methods
We conducted a secondary analysis of data from a multicenter, double-blind, randomized clinical trial comparing clomiphene citrate vs letrozole in the treatment of infertility in 750 women with PCOS (Pregnancy in Polycystic Ovary Syndrome II). 20 Subjects provided written, informed consent to participate in the clinical trial. This secondary analysis utilized only deidentified data, and was exempt from institutional review board approval accordingly.
Subjects
The study cohort included 732 female patients, ages 18e40 years, enrolled in the Pregnancy in Polycystic Ovary Syndrome II clinical trial at 1 of 11 centers. PCOS was diagnosed by modified Rotterdam criteria, 21 requiring chronic ovulatory dysfunction in addition to hyperandrogenism, or polycystic appearing ovaries, or both. Ovulatory dysfunction was defined as oligomenorrhea (ie 8 menses annually), a spontaneous intermenstrual interval of 45 days, or chronic anovulatory bleeding with midluteal serum progesterone of <3 ng/dL. Hyperandrogenism included hirsutism (modified Ferriman-Gallwey [mFG] score >8), or elevated serum testosterone or free androgen index. Polycystic morphology was defined per Rotterdam criteria as 12 antral follicles 2e9 mm in diameter, or increased ovarian volume >10 cm 3 in at least 1 ovary on transvaginal ultrasound. Related disorders were screened out by thyroid-stimulating hormone, prolactin, and 17-hydroxyprogesterone. Additional details regarding eligibility criteria are available publicly. 22 Subjects who completed both the PCOS Questionnaire (PCOSQ) and Primary Care Evaluation of Mental Disorders (PRIME-MD) Patient Health Questionnaire (PHQ) at the screening visit were included in this analysis.
At the screening visit, thorough history and physical examination, including calculation of body mass index (BMI), was performed. The mFG scoring system 23 was utilized to assess hirsutism.
Health-related quality of life
Validated instruments were selfadministered at the screening visit. HRQOL was assessed using the PCOSQ survey. 24 PCOSQ is a validated, Likerttype 26-item questionnaire, which examines 5 domains specifically targeted to quality of life (QOL) in PCOS: emotional disturbance, body hair, weight, menstrual problems, and infertility. Items query the severity and frequency of symptomatic distress related to PCOS. Reponses are coded from 1e7. Scoring of PCOSQ provides separate domain scores for each of the 5 domains, as the numeric mean of items in that domain, as well as a global score, as the mean of the 5 domain scores. Scores range from 1e7, with 1 indicating poorest function and highest distress, and 7 indicating optimal function and minimal distress.
Depression
The PRIME-MD PHQ 25 was used to assess depression. The PRIME-MD PHQ is a validated, self-administered questionnaire designed to diagnose specific mental disorders in the primary care setting, in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 26 The sensitivity and specificity (73% and 94%, respectively) for diagnosing depressive disorders are considered excellent compared to the gold standard structured clinical interview. 25 The survey assesses the frequency of 9 symptoms of clinical depression over the preceding 2 weeks. "Depression" is indicated by experiencing at least 3 of 9 symptoms on at least "more than half the days." One of these symptoms must be "little interest or pleasure in doing things" or "feeling down, depressed, or hopeless" or both, in accordance with Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
Statistical analysis
Descriptive statistics were provided. Baseline characteristics of depressed vs nondepressed women were compared using 2-sided t tests or c 2 as indicated; PCOSQ scores were compared using t tests. Univariate and multivariate linear regression models assessed the association between depression and PCOSQ domain and global scores. The multivariate model was adjusted for age, BMI, mFG score, and duration of infertility. To determine whether the relationship between a woman's BMI and her body weight PCOSQ score varied on the basis of whether or not she was depressed, a linear regression model incorporating an interaction term between depression and BMI was examined (outcome: body weight domain PCOSQ score). This analysis was repeated to evaluate potential interactions between depression and hirsutism score as predictors of body hair domain PCOSQ score, and between depression and duration of infertility as predictors of infertility domain PCOSQ AJOG at a Glance Why was this study conducted? To examine the association between depression and health-related quality of life (QOL) in polycystic ovary syndrome (PCOS).
Key findings
Reduced QOL was reported by depressed women for all PCOS-specific symptom domains, including: body hair, weight, infertility, menstrual disturbances, and emotions, and, in depressed women, differences in symptom distress were not accounted for by objective measures of body mass index, hirsutism scores, and infertility duration.
What does this add to what is known?
These findings suggest that depression may color how women experience PCOS symptoms and correspond to reduced QOL.
Original Research GYNECOLOGY ajog.org score. Statistical significance was set at the level of P < .05. Analyses were performed using software (STATA, Version 14.2; StataCorp, College Station, TX).
Results
Of the 732 women, 64 (8.4%) met criteria for depression by the PRIME-MD PHQ algorithm.
Baseline demographic and clinical characteristics are demonstrated in Table 1 . On average, subjects were 28.9 years old, with a BMI of 35.2 kg/m 2 . Most women were Caucasian (79%). While 20% had a prior live birth, average duration attempting conception was 42 months.
HRQOL scores as determined by PCOSQ were lower (ie, more distress) in all domains in the depressed compared to nondepressed subjects (Table 2) . QOL scores were lowest in the infertility domain, followed by body weight in both groups. In depressed women, the third most distressing domain was emotions, while the third most distressing domain for the nondepressed subjects was menstruation. The global PCOSQ score in the depressed women was 2.8 compared to 3.9 in the nondepressed group (P < .001), indicating lower overall HRQOL in women with depression.
Linear regression models further assessed the difference in PCOSQ scores between depressed and nondepressed women (Table 3 ). In unadjusted analyses, depression was associated with statistically significant reductions in QOL (ie, negative coefficients) in all domains and in the global score.
To assess whether clinically measurable parameters of PCOS symptom severity explained the impairment in HRQOL reported by the depressed women, we conducted multivariate linear regression analyses controlling for age, BMI, mFG score, and duration of infertility; the primary outcome was PCOSQ scores, and we considered depressed vs nondepressed group assignment as 1 predictor in the model (Table 3 ). The association of depressed status with reduced QOL in each of the 5 individual domains, as well as the global score, remained significant in the adjusted models. For example, after controlling for BMI, age, mFG, and infertility duration, depressed status was associated with a reduction in weight domain score by 1.23 points (95% confidence interval [CI], e1.63 to e0.83; P < .001), and a reduction in global HRQOL score by 0.98 points (95% CI, e1.23 to e0.73; P < .001) ( Table 3) .
To visualize the relationship between objective clinical measurements and subjective ratings of QOL distress, we constructed scatter plots with linear models by depressed vs nondepressed status (Figure) . Linear regression modeling incorporating interaction terms between depression and clinical measurements as predictors of subjective symptom severity assessed whether the relationship between the following varied on the basis of depression status: weight PCOSQ domain score vs BMI, body hair PCOSQ domain score vs mFG score, and infertility PCOSQ domain score vs duration of infertility (Figure) .
Among nondepressed women, weight-related QOL declined significantly with increasing BMI, with each 1-kg/m 2 increase in BMI corresponding to a 0.10-point reduction in weight Figure, B , depicts a similar analysis regarding body hair signs and symptoms. In both nondepressed and depressed women, body hair QOL scores declined with increasing mFG scores (depressed: coefficient, e0.14; 95% CI, e0.16 to e0.13; P < .001; and nondepressed: coefficient, e0.12; 95% CI, e0.17 to e0.08; P < .001). An interaction was not observed between depression and hirsutism score as predictors of body hairerelated QOL.
A comparison of infertility domain score vs duration of infertility showed increasing duration of infertility was associated with worsening QOL among nondepressed women (coefficient, e0.01; 95% CI, e0.01 to e0.00; P < .001), while among depressed women the inverse association was nonsignificant (coefficient, e0.00; 95% CI, e0.01 to 0.01; P ¼ .68) (Figure, C) . However, there was no statistically significant interaction between depression and infertility duration as predictors of infertility domain PCOSQ score (coefficient, 0.00; 95% CI, e0.01 to 0.01; P ¼ .40).
Comment
HRQOL is increasingly emphasized as an essential patient-reported outcome; it constitutes 1 of 4 foundation health measures and overarching goals of Healthy People 2020. 27 HRQOL is a multidimensional concept that includes physical, social, and emotional functioning. 27 Prior reports have shown a reduction in HRQOL in women with PCOS compared to controls. 13, 14 It is conceivable that psychological dysfunction, namely depression, might affect the perception and experience of physical symptoms related to disease.
In our study, we identified a global reduction in HRQOL in depressed women with PCOS compared to their nondepressed counterparts. Reduced scores, indicating increased symptomspecific distress, were noted in each of the 5 queried domains (ie, emotions, body hair, weight, menstruation, and infertility). These reductions in QOL reported by depressed women are arguably clinically as well as statistically significant, as a 0.5-point differential in PCOSQ scores is considered clinically meaningful. 28 The reported impairments in functioning in depressed women were not accounted for by corresponding objective clinical measures including BMI, hirsutism scores, and infertility duration in multivariate linear regression models.
Focusing further on the weight domain, we noted that the relationship between weight-specific HRQOL and BMI differed between depressed and Negative coefficient indicates reduction in quality of life in depressed women compared to nondepressed women.
Adjusted model includes: age, body mass index, modified Ferriman-Gallwey score, and duration of infertility.
Univariate and multivariate linear regression models were used in analyses, with depressed group coded as 1 and nondepressed coded as 0. Original Research GYNECOLOGY ajog.org nondepressed women. We identified a progressive reduction in weight domain QOL scores with increasing BMI in nondepressed women. Conversely, we failed to identify a statistically significant association in depressed women. An interaction was noted between depression and BMI, confirming that the effect of BMI on perceived weight distress differed on the basis of whether a woman was depressed or not. While the vast majority of prior literature examining the interplay of BMI, depression, and HRQOL focuses on mutual correlations, the concept that an interaction may exist between obesity and depression as predictors of HRQOL is supported by a prior population-based study that observed a synergistic effect between obesity and mental health disorders in their detrimental impact on HRQOL. 29 Regarding the infertility domain, we again observed a statistically significant association between infertility-specific QOL scores and duration of infertility in nondepressed women, but observed an attenuated, nonsignificant association in depressed women; however, the interaction term between depression and 
Associations between PCOSQ scores and corresponding clinical measurements among depressed and nondepressed subjects
Among depressed (navy blue triangles) and nondepressed (light gray circles) subjects, associations between Polycystic Ovary Syndrome Questionnaire (PCOSQ) domain scores and corresponding clinical measurements: A, weight domain and body mass index (kg/m 2 ); B, body hair domain and modified Ferriman-Gallwey (mFG) score; C, infertility domain and duration of infertility (months). PCOSQ domain scores are plotted along y-axis with lower scores indicating lower QOL (or increased distress) related to each symptom. Corresponding objective clinical measurements are plotted along x-axis. Linear models are shown in red and orange, for nondepressed and depressed subjects, respectively, with regression coefficients (coef) shown by text. Coefficient for interaction term between depressed status and objective clinical measurement (x-axis variable) as predictors of PCOSQ score (y-axis variable) are shown at top right of each plot. ajog.org GYNECOLOGY Original Research infertility duration was not significant in our model. In the body hair domain, increasing severity of clinician-rated hirsutism was associated with worse QOL scores for both depressed and nondepressed women, however, QOL was lower for depressed women.
Our multivariate model (Table 3 ) identified persistent reductions in weight and infertility domain PCOSQ scores in the depressed women, which were independent of BMI and infertility duration. Taken together, these findings suggest that depression might color the somatic symptom experience in PCOS, adding distress independent of objective findings. The alternative explanatione that women who viewed their PCOS symptoms more negatively were at increased risk for depressioneis also plausible.
Our data are consistent with a prior Turkish study that also observed impaired HRQOL functioning in depressed compared with nondepressed women with PCOS seen in an endocrinology clinic. 17 Our study extends the prior findings by taking into account baseline differences between groups (eg, BMI and mFG scores) to address this potential source of confounding. Comparing depressed women across studies, we found that infertility and weight problems were the most serious concerns, while hair growth and menstrual disturbances were most distressing in the Turkish population, 17 reflecting the different clinical compositions and perhaps cultural differences. Another recent study investigating clinician vs patient self-rating of hirsutism in PCOS determined that while both ratings were associated with a negative QOL impact, self-ratings alone were associated with the risk of depression, 15 echoing our findings of the association between selfreported symptom-specific distress and depression.
Psychological well-being is paramount in PCOS. One prior investigation determined that PCOS had a greater negative impact on psychological HRQOL functioning compared to arthritis, back pain, epilepsy, and coronary heart disease, as measured by the 36-Item Short Form Health Survey (SF-36).
14 Decreased psychological functioning may have critical implications for long-term health. Lifestyle modification including diet and exercise are primary treatment strategies to combat cardiometabolic risk in PCOS and may ameliorate some PCOS features, such as obesity, cycle irregularity, and infertility. Depression can negatively impact the motivation required for efforts at selfcare, further exacerbating the effects of PCOS. 30 Indeed, cognitive theories of depression focused on "learned helplessness" suggest that depression might evolve when an individual, following repeated unpleasant experiences, no longer attempts to change their situation due to a sense of lacking control. 31 Conversely, perceiving that one's actions (eg, pursuing diet and exercise) could improve health is prerequisite for motivation to produce a change. Thus, depression might precipitate a vicious and compounding cycle in PCOS: a perception of lack of control to improve health status may lead to depression, which further impedes efforts to improve lifestyle habits, in turn resulting worsening symptoms and metabolic decline.
The results of our study underscore the importance of symptom self-report in the context of patient-centered care and suggest that clinicians should consider depression when encountering patients with a notable sign-symptom mismatch. Further, our findings suggest the possibility that adequate treatment of depression might improve PCOS symptom selfperception and HRQOL dysfunction. The converse, that treatment of distressing PCOS clinical symptomatology might improve depression, is also possible. Pharmacotherapy and psychotherapy are both effective treatment modalities for depression symptoms, and evidence supports a combined approach as most effective. 32 In light of our findings demonstrating perturbations in symptom self-perception related to the PCOS disease state among depressed women, therapies targeted at helping women reevaluate their thinking about PCOS, such as cognitive behavioral therapy, should be strongly considered in a treatment approach to ameliorate depressive symptoms and improve HRQOL.
Strengths, limitations, and future directions
Strengths of our study include the large sample size representing 11 centers nationwide. Limitations inherent in the cross-sectional design restrict our interpretation of causal direction. While it is possible depression might result in heightened distress from somatic symptoms by coloring self-perception, it is also possible escalated perception of symptom burden might contribute to depression. In addition, the smaller sample size in the depressed group may impact statistical power to detect associations between objective and subjective findings in the interaction models. However, with regards to the weight domain, the statistically significant interaction identified between depression and BMI confirmed that the impact of BMI on weight-related QOL differs as a function of whether or not a woman is depressed. Further, the findings from our multivariate regression models corroborate the overall concept that the reduction in HRQOL in the depressed group is not fully explained by objective clinical measures. By nature of design, our study is limited to infertile women with PCOS; if and how our results might vary in fertile women with PCOS cannot be extrapolated from this report. Finally, the prevalence of depression in this cohort was low (8.4%) relative to prior reports in other PCOS populations (average 37%). 8 This may reflect the relative rigor of the PRIME-MD screening algorithm, and/or the selection of motivated individuals in pursuit of eligibility to participate in a clinical trial of fertility treatment. Studies that seek to replicate our findings in alternate clinical cohorts are needed.
In conclusion, we demonstrate an association between depression and HRQOL in PCOS unexplained by objective measures. Our data suggest that depression may color the perception of somatic symptoms of PCOS, uncoupling the subjective experience from objective clinical measurements. Our data indicate the utility of future prospective, interventional studies to ascertain whether the treatment of depression improves subjective 
